December 20, 2012 — Less than six months after the U.S. Food and Drug Administration (FDA) recalled the dietary supplement Reumofan and Reumofan Plus, the manufacturer has re-branded it as “WOW” with the same dangerous ingredients, and they continue to sell Reumofan online. The products are marketed as a treatment for arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. Until the FDA takes stronger enforcement action, they are warning the public about the dangers of this product in a Drug Safety Communication.
Although the FDA has published two warnings this year (one in June and one in August), the manufacturer refuses to issue an adequate recall of the product. The FDA’s Acting Associate Commissioner for Regulatory Affairs, Melinda Plaisier, warned:
“FDA is prepared to take aggressive enforcement action to protect consumers from these dangerous products, including seizure, injunction, and pursuit of criminal prosecution.”
The problem with Reumofan and “WOW” is that they are labeled as dietary supplements, but they actually contain prescription drug ingredients that are not listed on the label. It is also illegal for supplements to contain active pharmaceutical drug ingredients. FDA tests of Reumofan and “WOW” have found the same drug ingredients:
- Dexamethasone: A corticosteroid
- Diclofenac sodium: A non-steroidal anti-inflammatory drug
- Methocrabamol: A muscle relaxant
These drugs can have life-threatening side effects, especially if they are combined with other medications. The FDA has received dozens of reports of people who have been seriously injured. Potential side effects include, but are not limited to:
- Liver injury
- Severe bleeding
- Corticosteroid withdrawal syndrome
- Adrenal suppression
- Stroke
- Death
Do I have a Reumofan Lawsuit?
The Schmidt Firm, PLLC is currently accepting Reumofan and “WOW” induced injury cases in all 50 states. If you or somebody you know has been injured by Reumofan or “WOW,” you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.